Urology News and Research

Latest Urology News and Research

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

Predictive Biosciences, a provider of novel molecular diagnostic tests, announced that on June 7, 2011 the U.S. Patent and Trademark Office issued Patent Number 7,955,822 for "Detection of Nucleic Acids and Proteins".

17 Jun 2011

Low testosterone linked to varicoceles

As many as 15 percent of men have varicoceles, masses of enlarged and dilated veins in the testicles. There is new evidence that varicoceles, long known to be a cause of male infertility, interfere with the production of testosterone -- a crucial hormone to maintaining men's health. There is good news too: Microsurgery can increase testosterone levels in these men. Results of new research by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are in a recent edition of BJU International.

16 Jun 2011

Children's Medical Center to open new $21M Specialty Care Center in Southlake

Children's Medical Center will debut its new Specialty Care Center in Southlake on June 18, a $21 million expansion which will serve children in one of the state's fastest-growing cities and the surrounding communities.

16 Jun 2011

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

UCSF's Robert Blelloch, MD, PhD, has received the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research, for his pioneering research on the role of molecular tools known as microRNAs in embryonic stem cells and cancer.

16 Jun 2011

Tubularized incised plate procedure effective for boys with hypospadias

A pediatric urologist at UT Southwestern Medical Center who pioneered a surgical technique for repairing a common birth defect in boys reports the procedure is singularly effective in correcting the problem with few complications.

15 Jun 2011

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Ambit Biosciences Corporation and Astellas Pharma Inc. announced today results from a planned interim analysis in an ongoing Phase 2 study evaluating AC220, a potent and selective FLT3 inhibitor.

14 Jun 2011

Mother to donate her womb to daughter

A 56-year-old mother hopes to become the first woman to have her womb transplanted into her daughter. Eva Ottoson who lives in Nottinghamshire has agreed to take part in the medical procedure that would see her donate her uterus to her daughter.

13 Jun 2011

Avvo.com, cites top 10 most popular medical specialty categories based on website's patient usage

Avvo (www.avvo.com), the world's largest online directory for doctors and lawyers that provides free rankings for 90% of the working physicians in the U.S., today revealed the most popular medical specialty categories based on Q1 2011 metrics quantifying patient participation in Avvo's online services that include searching Avvo's physician directory, asking health related questions in the Q&A forum, and submitting reviews on their doctors' Avvo profiles.

9 Jun 2011

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that Seattle Genetics has exercised an option to co-develop a second antibody-drug conjugate (ADC) under the companies' existing ADC collaboration agreement.

9 Jun 2011

Cabozantinib shows early promise in treatment of prostate cancer spread to the bone

A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows.

8 Jun 2011

FDA clears ArthroCare's Spartan 6.5 Needled Anchor

ArthroCare® Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan™ 6.5 Needled Anchor (Spartan). The Spartan device is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

6 Jun 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Genentech, a member of the Roche Group and Astellas Pharma US, Inc., today announced results of EURTAC, the first Phase III study with Tarceva in Western patients with a genetically distinct type of advanced non-small cell lung cancer (NSCLC).

4 Jun 2011

SBRT is effective for patients with low-to-intermediate-risk prostate cancer: Researchers

In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.

4 Jun 2011

Mount Sinai to participate in Medtronic CoreValve U.S. Clinical Trial

Mount Sinai Medical Center in Miami Beach, Florida announced its participation in the Medtronic CoreValve U.S. Clinical Trial, which will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis. Mount Sinai is now among a select number of leading hospitals across the U.S. to participate in this trial.

From Medtronic 4 Jun 2011

ZYTIGA clinical study data on prostate cancer to be presented at ASCO 2011

Data related to ZYTIGA (abiraterone acetate) will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

3 Jun 2011

APC8015F investigational vaccine improves survival of prostate cancer patients

Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4.

3 Jun 2011

Stereotactic body radiation therapy effective for patients with low-risk prostate cancer

3 Jun 2011

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

A cell phone-sized, wireless near-infrared device is as reliable as the current "gold standard" invasive tests in determining bladder disease, according to a study by researchers at the University of British Columbia, Vancouver Coastal Health and the Child & Family Research Institute (CFRI).

1 Jun 2011

FDA approves Oceana's Solesta for treatment of fecal incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, announced that the U.S. Food and Drug Administration has approved Solesta as a treatment for fecal incontinence in adult patients who have failed conservative therapy such as dietary control.

31 May 2011

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

30 May 2011

Urology News and Research

Latest Urology News and Research

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

Low testosterone linked to varicoceles

Children's Medical Center to open new $21M Specialty Care Center in Southlake

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

Tubularized incised plate procedure effective for boys with hypospadias

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Mother to donate her womb to daughter

Avvo.com, cites top 10 most popular medical specialty categories based on website's patient usage

Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors

Cabozantinib shows early promise in treatment of prostate cancer spread to the bone

FDA clears ArthroCare's Spartan 6.5 Needled Anchor

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

SBRT is effective for patients with low-to-intermediate-risk prostate cancer: Researchers

Mount Sinai to participate in Medtronic CoreValve U.S. Clinical Trial

ZYTIGA clinical study data on prostate cancer to be presented at ASCO 2011

APC8015F investigational vaccine improves survival of prostate cancer patients

Stereotactic body radiation therapy effective for patients with low-risk prostate cancer

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

FDA approves Oceana's Solesta for treatment of fecal incontinence

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Urology News and Research

Latest Urology News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in